$KNSA Kiniksa Pharmaceuticals, Ltd. Insider Trading Week 21/2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Kiniksa Pharmaceuticals, Ltd..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Kiniksa Pharmaceuticals, Ltd. in week 21/2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 31 2018 | KNSA | Kiniksa Pharmaceut ... | Flynn James E | 10% Owner | Option Exercise | C | 0.00 | 383,538 | 0 | 0 | |
| May 31 2018 | KNSA | Kiniksa Pharmaceut ... | Flynn James E | 10% Owner | Buy | P | 19.24 | 235,019 | 4,520,943 | 843,352 | 608.3 K to 843.4 K (+38.63 %) |
| May 31 2018 | KNSA | Kiniksa Pharmaceut ... | Flynn James E | 10% Owner | Buy | P | 20.91 | 25,000 | 522,748 | 608,333 | 583.3 K to 608.3 K (+4.29 %) |
| May 31 2018 | KNSA | Kiniksa Pharmaceut ... | Flynn James E | 10% Owner | Buy | P | 19.81 | 250,000 | 4,953,150 | 583,333 | 333.3 K to 583.3 K (+75.00 %) |
| May 31 2018 | KNSA | Kiniksa Pharmaceut ... | Flynn James E | 10% Owner | Buy | P | 18.00 | 333,333 | 5,999,994 | 333,333 | 0 to 333.3 K |
| May 31 2018 | KNSA | Kiniksa Pharmaceut ... | Flynn James E | 10% Owner | Buy | C | 0.00 | 383,538 | 0 | 383,538 | 0 to 383.5 K |
| May 31 2018 | KNSA | Kiniksa Pharmaceut ... | Cormorant Asset Management, LP | 10% Owner | Option Exercise | C | 0.00 | 830,999 | 0 | 0 | |
| May 31 2018 | KNSA | Kiniksa Pharmaceut ... | Cormorant Asset Management, LP | 10% Owner | Buy | P | 18.00 | 69,444 | 1,249,992 | 900,443 | 831 K to 900.4 K (+8.36 %) |
| May 31 2018 | KNSA | Kiniksa Pharmaceut ... | Cormorant Asset Management, LP | 10% Owner | Buy | C | 0.00 | 830,999 | 0 | 830,999 | 0 to 831 K |
| May 31 2018 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 14,658,102 | 0 | 14,658,102 | |
| May 31 2018 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 14,658,102 | 0 | 0 | |
| May 31 2018 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 1,399,516 | 0 | 1,399,516 | |
| May 31 2018 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 1,399,516 | 0 | 0 | |
| May 31 2018 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 3,284,771 | 0 | 7,018,874 | |
| May 31 2018 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 3,284,771 | 0 | 0 | |
| May 31 2018 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 313,621 | 0 | 734,518 | |
| May 31 2018 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 313,621 | 0 | 0 | |
| May 31 2018 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 3,734,103 | 0 | 3,734,103 | |
| May 31 2018 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 3,734,103 | 0 | 0 | |
| May 31 2018 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 420,897 | 0 | 420,897 | |
| May 31 2018 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 420,897 | 0 | 0 | |
| May 31 2018 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | P | 0.00 | 3,734,103 | 0 | 3,734,103 | |
| May 31 2018 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | P | 0.00 | 420,897 | 0 | 420,897 | |
| May 31 2018 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 18.00 | 2,700,597 | 48,610,746 | 2,700,597 | 0 to 2.7 M |
| May 31 2018 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 18.00 | 299,403 | 5,389,254 | 299,403 | 0 to 299.4 K |
| May 29 2018 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Option Exercise | C | 0.00 | 428,203 | 0 | 1,526,160 | |
| May 29 2018 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Option Exercise | C | 0.00 | 63,922 | 0 | 0 | |
| May 29 2018 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Option Exercise | C | 0.00 | 71,967 | 0 | 0 | |
| May 29 2018 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Option Exercise | C | 0.00 | 428,203 | 0 | 0 | |
| May 29 2018 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Option Exercise | P | 0.00 | 63,922 | 0 | 63,922 | |
| May 29 2018 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Buy | C | 0.00 | 135,889 | 0 | 245,685 | 109.8 K to 245.7 K (+123.76 %) |
| May 29 2018 | KNSA | Kiniksa Pharmaceut ... | Beetham Thomas W. | Chief Legal Officer | Option Exercise | C | 0.00 | 48,172 | 0 | 414,157 | |
| May 29 2018 | KNSA | Kiniksa Pharmaceut ... | Beetham Thomas W. | Chief Legal Officer | Option Exercise | C | 0.00 | 6,392 | 0 | 0 | |
| May 29 2018 | KNSA | Kiniksa Pharmaceut ... | Beetham Thomas W. | Chief Legal Officer | Option Exercise | C | 0.00 | 48,172 | 0 | 0 | |
| May 29 2018 | KNSA | Kiniksa Pharmaceut ... | Beetham Thomas W. | Chief Legal Officer | Option Exercise | P | 0.00 | 6,392 | 0 | 6,392 | |
| May 29 2018 | KNSA | Kiniksa Pharmaceut ... | Beetham Thomas W. | Chief Legal Officer | Buy | C | 0.00 | 6,392 | 0 | 79,589 | 73.2 K to 79.6 K (+8.73 %) |
| May 29 2018 | KNSA | Kiniksa Pharmaceut ... | Malley Thomas | Director | Option Exercise | C | 0.00 | 71,967 | 0 | 0 | |
| May 29 2018 | KNSA | Kiniksa Pharmaceut ... | Malley Thomas | Director | Buy | C | 0.00 | 71,967 | 0 | 71,967 | 0 to 72 K |
| May 29 2018 | KNSA | Kiniksa Pharmaceut ... | BOESS CARSTEN | 10% Owner | Option Exercise | C | 0.00 | 107,050 | 0 | 473,035 | |
| May 29 2018 | KNSA | Kiniksa Pharmaceut ... | BOESS CARSTEN | 10% Owner | Option Exercise | C | 0.00 | 6,392 | 0 | 0 | |
| May 29 2018 | KNSA | Kiniksa Pharmaceut ... | BOESS CARSTEN | 10% Owner | Option Exercise | C | 0.00 | 107,050 | 0 | 0 | |
| May 29 2018 | KNSA | Kiniksa Pharmaceut ... | BOESS CARSTEN | 10% Owner | Option Exercise | P | 0.00 | 6,392 | 0 | 6,392 | |
| May 29 2018 | KNSA | Kiniksa Pharmaceut ... | BOESS CARSTEN | 10% Owner | Buy | C | 0.00 | 6,392 | 0 | 79,589 | 73.2 K to 79.6 K (+8.73 %) |
| May 29 2018 | KNSA | Kiniksa Pharmaceut ... | Mahoney Stephen F. | President & COO | Option Exercise | C | 0.00 | 107,050 | 0 | 656,027 | |
| May 29 2018 | KNSA | Kiniksa Pharmaceut ... | Mahoney Stephen F. | President & COO | Option Exercise | C | 0.00 | 6,392 | 0 | 0 | |
| May 29 2018 | KNSA | Kiniksa Pharmaceut ... | Mahoney Stephen F. | President & COO | Option Exercise | C | 0.00 | 107,050 | 0 | 0 | |
| May 29 2018 | KNSA | Kiniksa Pharmaceut ... | Mahoney Stephen F. | President & COO | Option Exercise | P | 0.00 | 6,392 | 0 | 6,392 | |
| May 29 2018 | KNSA | Kiniksa Pharmaceut ... | Mahoney Stephen F. | President & COO | Buy | C | 0.00 | 6,392 | 0 | 79,589 | 73.2 K to 79.6 K (+8.73 %) |
| May 29 2018 | KNSA | Kiniksa Pharmaceut ... | Heberlig Chris | Exec VP & CFO | Option Exercise | C | 0.00 | 74,935 | 0 | 440,920 | |
| May 29 2018 | KNSA | Kiniksa Pharmaceut ... | Heberlig Chris | Exec VP & CFO | Option Exercise | C | 0.00 | 6,392 | 0 | 0 | |
| May 29 2018 | KNSA | Kiniksa Pharmaceut ... | Heberlig Chris | Exec VP & CFO | Option Exercise | C | 0.00 | 74,935 | 0 | 0 | |
| May 29 2018 | KNSA | Kiniksa Pharmaceut ... | Heberlig Chris | Exec VP & CFO | Option Exercise | P | 0.00 | 6,392 | 0 | 6,392 | |
| May 29 2018 | KNSA | Kiniksa Pharmaceut ... | Heberlig Chris | Exec VP & CFO | Buy | C | 0.00 | 6,392 | 0 | 42,991 | 36.6 K to 43 K (+17.46 %) |